PulseAugur
EN
LIVE 06:26:28
中文(ZH) 上海医药、君实生物等成立新私募基金，出资额15亿

Shanghai Pharmaceuticals and Junshi Biosciences launch 1.5B RMB private equity fund

By PulseAugur Editorial · [1 sources] ·

A new private equity fund, Shanghai Shangshi Biomedical Industry Private Equity Fund Partnership (Limited Partnership), has been established with a capital contribution of 1.5 billion RMB. The fund's business scope includes equity investment, investment management, and asset management. Key contributors to the fund include Shanghai State-owned Capital Advanced Biomedical Private Equity Investment Fund Partnership (Limited Partnership), Shanghai Pharmaceuticals Holding Co., Ltd., and Shanghai Junshi Biosciences Co., Ltd. AI

RANK_REASON Significant funding round for a new private equity fund involving major pharmaceutical companies. [lever_c_demoted from significant: ic=1 ai=0.0]

Read on 36氪 (36Kr) →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

Shanghai Pharmaceuticals and Junshi Biosciences launch 1.5B RMB private equity fund

COVERAGE [1]

  1. 36氪 (36Kr) TIER_1 中文(ZH) ·

    Shanghai Pharmaceuticals, Junshi Biosciences, and others establish a new private equity fund with a capital contribution of 1.5 billion

    36氪获悉，天眼查App显示，近日，上海上实生物医药产业私募基金合伙企业（有限合伙）成立，执行事务合伙人为上海上实资本管理有限公司、上海上实生物医药管理咨询有限公司，出资额15亿人民币，经营范围为以私募基金从事股权投资、投资管理、资产管理等活动。合伙人信息显示，该基金由上海国投先导生物医药私募投资基金合伙企业（有限合伙）、上海医药集团股份有限公司、上海君实生物医药科技股份有限公司等共同出资。

RELATED TOPICS